Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 6/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70379 | 0.85 | ALOX5 (0.70) | ALOX5PTGS2CYP3A4MAPTMAOB | |
| Ethane SCHEMBL27660205 | 0.82 | ALOX5 (0.67) | ALOX5PTGS2CYP3A4MAPTMAOB | |
| SCHEMBL678214 | 0.81 | ERN1 (0.57) | ALOX5PTGS2MAPTEGFRCA12 | |
| SCHEMBL683246 | 0.81 | CYP3A4 (0.56) | ALOX5PTGS2CYP3A4MAPTMAOB | |
| SCHEMBL67495 | 0.80 | PTGS2 (0.64) | ALOX5PTGS2CYP3A4MAPTEGFR | |
| SCHEMBL11581623 | 0.79 | ABL1 (0.52) | ALOX5PTGS2CYP3A4EGFRCA12 | |
| SCHEMBL17265618 | 0.79 | CYP3A4 (0.74) | ALOX5PTGS2CYP3A4MAPTMAOB | |
| SCHEMBL29421987 | 0.79 | CYP3A4 (0.74) | ALOX5PTGS2CYP3A4MAPTMAOB | |
| SCHEMBL24161883 | 0.78 | PTGS2 (0.61) | ALOX5PTGS2CYP3A4MAPTMAOB | |
| SCHEMBL7289424 | 0.77 | CYP3A4 (0.62) | ALOX5PTGS2CYP3A4MAPTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11831017-B2 | Redox flow battery electrolytes | CMBLU ENERGY AG (DE) | 2023-11-28 | — | — | US | disclosed |
| US-11788228-B2 | Methods for processing lignocellulosic material | CMBLU ENERGY AG (DE) | 2023-10-17 | — | — | US | disclosed |
| US-11773537-B2 | Sulfonated lignin-derived compounds and uses thereof | CMBLU ENERGY AG (DE) | 2023-10-03 | — | — | US | disclosed |
| US-20230304221-A1 | Sulfonated Lignin-Derived Compounds And Uses Thereof | CMBLU ENERGY AG (DE) | 2023-09-28 | — | — | US | disclosed |
| US-20230160143-A9 | Sulfonated Lignin-Derived Compounds and uses Thereof | CMBLU PROJEKT AG (DE) | 2023-05-25 | — | — | US | disclosed |
| US-20230130406-A1 | Redox Flow Battery Electrolytes | CMBLU PROJEKT AG (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20130129832-A1 | COGNITIVE IMPAIRMENT AMELIORANT | TOHOKU UNIVERSITY (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20110287106-A1 | COGNITIVE IMPAIRMENT AMELIORANT | JAPAN ROYAL JELLEY CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
| US-7314693-B2 | Electrophotographic photoconductor, electrophotographic process, electrophotographic apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2008-01-01 | — | — | US | disclosed |
| EP-0065720-B1 | PROCESS FOR PREPARING HYDROXYPHENYL AMINE DERIVATIVES | CASSELLA Aktiengesellschaft (DE) | 1985-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230160143-A9 | Sulfonated Lignin-Derived Compounds and uses Thereof | SQOR, NQO1, NOX4 | ALOX5 540/4885PTGS2 2608/4885CYP3A4 481/4885 |
| US-11788228-B2 | Methods for processing lignocellulosic material | DCXR, LCT, AGL | ALOX5 338/4885PTGS2 1885/4885CYP3A4 794/4885 |
| US-11773537-B2 | Sulfonated lignin-derived compounds and uses thereof | SQOR, NQO1, NOX4 | ALOX5 540/4885PTGS2 2608/4885CYP3A4 481/4885 |
| US-20130129832-A1 | COGNITIVE IMPAIRMENT AMELIORANT | CHAT, ACHE, PSEN1 | ALOX5 467/4885PTGS2 1789/4885CYP3A4 4098/4885 |
| US-20230130406-A1 | Redox Flow Battery Electrolytes | GPX1, GPX4, NOX4 | ALOX5 1369/4885PTGS2 1798/4885CYP3A4 368/4885 |
| US-11831017-B2 | Redox flow battery electrolytes | GPX1, GPX4, NOX4 | ALOX5 1369/4885PTGS2 1798/4885CYP3A4 368/4885 |
| US-20230304221-A1 | Sulfonated Lignin-Derived Compounds And Uses Thereof | SQOR, NQO1, NOX4 | ALOX5 540/4885PTGS2 2608/4885CYP3A4 481/4885 |
| US-20110287106-A1 | COGNITIVE IMPAIRMENT AMELIORANT | CHAT, ACHE, PSEN1 | ALOX5 467/4885PTGS2 1789/4885CYP3A4 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.